Literature DB >> 3288280

Biosynthesis of lipid A in Escherichia coli: identification of UDP-3-O-[(R)-3-hydroxymyristoyl]-alpha-D-glucosamine as a precursor of UDP-N2,O3-bis[(R)-3-hydroxymyristoyl]-alpha-D-glucosamine.

M S Anderson1, A D Robertson, I Macher, C R Raetz.   

Abstract

The lipid A disaccharide of the Escherichia coli envelope is synthesized from the two fatty acylated glucosamine derivatives UDP-N2,O3-bis[(R)-3-hydroxytetradecanoyl]-alpha-D- glucosamine (UDP-2,3-diacyl-GlcN) and N2,O3-bis[(R)-3-hydroxytetradecanoyl]-alpha-D-glucosamine 1-phosphate (2,3-diacyl-GlcN-1-P) [Ray, B. L., Painter, G., & Raetz, C. R. H. (1984) J. Biol. Chem. 259, 4852-4859]. We have previously shown that UDP-2,3-diacyl-GlcN is generated in extracts of E. coli by fatty acylation of UDP-GlcNAc, giving UDP-3-O-[(R)-3-hydroxymyristoyl]-GlcNAc as the first intermediate, which is rapidly converted to UDP-2,3-diacyl-GlcN [Anderson, M. S., Bulawa, C. E., & Raetz, C. R. H. (1985) J. Biol. Chem. 260, 15536-15541; Anderson, M. S., & Raetz, C. R. H. (1987) J. Biol. Chem. 262, 5159-5169]. We now demonstrate a novel enzyme in the cytoplasmic fraction of E. coli, capable of deacetylating UDP-3-O-[(R)-3-hydroxymyristoyl]-GlcNAc to form UDP-3-O-[(R)-3-hydroxymyristoyl]glucosamine. The covalent structure of the previously undescribed UDP-3-O-[(R)-3-hydroxymyristoyl] glucosamine intermediate was established by 1H NMR spectroscopy and fast atom bombardment mass spectrometry. This material can be made to accumulate in E. coli extracts upon incubation of UDP-3-O-[(R)-3- hydroxymyristoyl]-GlcNAc in the absence of the fatty acyl donor [(R)-3-hydroxymyristoyl]-acyl carrier protein. However, addition of the isolated deacetylation product [UDP-3-O-[(R)-3-hydroxymyristoyl] glucosamine] back to membrane-free extracts of E. coli in the presence of [(R)-3-hydroxymyristoyl]-acyl carrier protein results in rapid conversion of this compound into the more hydrophobic products UDP-2,3-diacyl-GlcN, 2,3-diacyl-GlcN-1-P, and O-[2-amino-2-deoxy-N2,O3- bis[(R)-3-hydroxytetradecanoyl]-beta-D-glucopyranosyl]-(1----6)-2-amino- 2-deoxy-N2,O3-bis[(R)-3-hydroxytetradecanoyl]-alpha-D- glucopyranose 1-phosphate (tetra-acyldisaccharide-1-P), demonstrating its competency as a precursor. In vitro incubations using [acetyl-3H]UDP-3-O-[(R)-3-hydroxymyristoyl]-GlcNAc confirmed release of the acetyl moiety in this system as acetate, not as some other acetyl derivative. The deacetylation reaction was inhibited by 1 mM N-ethylmaleimide, while the subsequent N-acylation reaction was not. Our observations provide strong evidence that UDP-3-O-[(R)-3-hydroxymyristoyl]glucosamine is a true intermediate in the biosynthesis of UDP-2,3-diacyl-GlcN and lipid A.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3288280     DOI: 10.1021/bi00406a017

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  28 in total

Review 1.  Lipopolysaccharide endotoxins.

Authors:  Christian R H Raetz; Chris Whitfield
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

2.  Crystal structure of LpxC, a zinc-dependent deacetylase essential for endotoxin biosynthesis.

Authors:  Douglas A Whittington; Kristin M Rusche; Hyunshun Shin; Carol A Fierke; David W Christianson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-20       Impact factor: 11.205

3.  Structure of the LpxC deacetylase with a bound substrate-analog inhibitor.

Authors:  Brian E Coggins; Xuechen Li; Amanda L McClerren; Ole Hindsgaul; Christian R H Raetz; Pei Zhou
Journal:  Nat Struct Biol       Date:  2003-08

4.  Structure of the metal-dependent deacetylase LpxC from Yersinia enterocolitica complexed with the potent inhibitor CHIR-090 .

Authors:  Kathryn E Cole; Samuel G Gattis; Heather D Angell; Carol A Fierke; David W Christianson
Journal:  Biochemistry       Date:  2010-12-20       Impact factor: 3.162

5.  Mechanistic inferences from the binding of ligands to LpxC, a metal-dependent deacetylase.

Authors:  Heather A Gennadios; Douglas A Whittington; Xuechen Li; Carol A Fierke; David W Christianson
Journal:  Biochemistry       Date:  2006-07-04       Impact factor: 3.162

6.  Profile of Christian R. H. Raetz.

Authors:  Nick Zagorski
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-23       Impact factor: 11.205

7.  Crystal structure of LpxC from Pseudomonas aeruginosa complexed with the potent BB-78485 inhibitor.

Authors:  Igor Mochalkin; John D Knafels; Sandra Lightle
Journal:  Protein Sci       Date:  2008-03       Impact factor: 6.725

8.  Binding of uridine 5'-diphosphate in the "basic patch" of the zinc deacetylase LpxC and implications for substrate binding.

Authors:  Heather A Gennadios; David W Christianson
Journal:  Biochemistry       Date:  2006-11-30       Impact factor: 3.162

9.  A slow, tight-binding inhibitor of the zinc-dependent deacetylase LpxC of lipid A biosynthesis with antibiotic activity comparable to ciprofloxacin.

Authors:  Amanda L McClerren; Stephanie Endsley; Jason L Bowman; Niels H Andersen; Ziqiang Guan; Johannes Rudolph; Christian R H Raetz
Journal:  Biochemistry       Date:  2005-12-20       Impact factor: 3.162

Review 10.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.